Mood Ingredients Market - 2025-2033

February 2026 | 245 pages | ID: M152CA41FF9BEN
DataM Intelligence

Abstracts

The Mood Ingredients Market was valued at US$ 249.96 million in 2025 and is anticipated to reach US$ 428.83 million by 2033, at a CAGR of 0.0698 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Mood Ingredients Market.

This report delivers a comprehensive overview of the Mood Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mood Ingredients Market. The Mood Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

Mood Ingredients Market Scope:

By Ingredient Type

• Botanical Extracts
• Proteins and Amino Acids
• Vitamins and Minerals
• Probiotics and Postbiotics
• Omega Fatty Acids
• Others

By Application

• Dietary Supplements
• Functional Foods and Beverages
• Personal Care and Beauty Products
• Pet Nutrition and Supplements
• Pharmaceuticals
• Others

By Health Benefit

• Stress Reduction
• Mood Elevation
• Anxiety Relief
• Sleep Support
• Cognitive Balance and Focus
• Hormonal Mood Regulation
• Others

By Source

• Plant-Based
• Animal-Based
• Synthetic or Bioidentical
• Fermented or Biotechnological

By Distribution Channel

• B2B Ingredient Suppliers
• B2C

Key Players

• DSM-Firmenich
• BASF SE
• Archer Daniels Midland Company (ADM)
• Cargill, Incorporated
• Kerry Group plc
• Ingredion Incorporated
• Tate & Lyle PLC
• International Flavors & Fragrances, Inc. (IFF)
• Ajinomoto Co., Inc.
• Lonza Group AG

Major Highlights

This report delivers a comprehensive overview of the Mood Ingredients Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mood Ingredients Market. The Mood Ingredients Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2025–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Data
  1.1.1. Secondary Data
  1.1.2. Primary Data
  1.1.3. CAGR Analysis
1.2. Market Size Estimation Methodology
  1.2.1. Bottom-Up Approach
  1.2.2. Top-Down Approach
1.3. Market Breakdown & Data Triangulation
1.4. Research Assumptions
1.5. Limitations

2. DEFINITION AND OVERVIEW

2.1. Study Objectives
2.2. Market Definition
2.3. Market Scope
2.4. Stakeholder Analysis
2.5. Currency Considered
2.6. Study Period

3. EXECUTIVE SUMMARY

3.1. Key Takeaways
3.2. Top To Bottom Analysis
3.3. Market Share Analysis
3.4. Data Points from Key Primary Interviews
3.5. Data Points from Key Secondary Databases
3.6. Market Snapshot
3.7. Geographical Snapshot

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Prevalence of Stress and Anxiety Disorders
    4.1.1.2. Expansion of Personalized Nutrition
4.2. Restraints
  4.2.1. Regulatory Complexity and Market Adoption Challenges
  4.2.2. Impact Analysis – Drivers and Restraints
  4.2.3. Opportunity
    4.2.3.1. Expansion in Functional Foods and Beverages
    4.2.3.2. Technological Innovation in Delivery Formats
  4.2.4. Trends
  4.2.5. Challenges

5. INDUSTRY ANALYSIS

5.1. Porter’s Five Force Analysis
5.2. Political Factors
5.3. Social Factors
  5.3.1. Changing Consumer Trends
  5.3.2. Population Growth
  5.3.3. Demographic Shifts
5.4. Economic Factors
  5.4.1. Interest Rates
  5.4.2. Disposable Incomes
  5.4.3. Inflation
  5.4.4. GDP
  5.4.5. Exchange Rates
  5.4.6. Unemployment Rates
5.5. Geopolitical Factors
5.6. Supply/Value Chain Analysis
5.7. Pricing Analysis
5.8. Tariff Analysis
  5.8.1. Overview Of Relevant Tariffs
  5.8.2. Trade Policies Influencing the Market
  5.8.3. Cost Impact Factors
  5.8.4. Supply Chain Disruptions
5.9. Trade Analysis - Export-Import Scenario
5.10. Regulatory Analysis
5.11. Technology Landscape
5.12. Go-To-Market (GTM) Strategy
5.13. Innovation & R&D Trends
5.14. Sustainability and ESG Analysis
5.15. Key Strategic Initiatives
  5.15.1. Emerging Players and Startups
  5.15.2. Major Players
5.16. DMI Opinion

6. BY INGREDIENT TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  6.1.2. Market Attractiveness Index, By Ingredient Type
6.2. Botanical Extracts*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  6.2.3. Adaptogens
  6.2.4. Ashwagandha
  6.2.5. Rhodiola Rosea
  6.2.6. Ginseng
  6.2.7. Others
6.3. Proteins and Amino Acids
  6.3.1. L-Theanine
  6.3.2. Tryptophan
  6.3.3. Tyrosine
  6.3.4. Others
6.4. Vitamins and Minerals
  6.4.1. Vitamin B6
  6.4.2. Vitamin B12
  6.4.3. Folate
  6.4.4. Magnesium
  6.4.5. Zinc
  6.4.6. Others
6.5. Probiotics and Postbiotics
  6.5.1. Lactobacillus strains
  6.5.2. Bifidobacterium strains
  6.5.3. Others
6.6. Omega Fatty Acids
  6.6.1. Omega-3
  6.6.2. Omega-6
6.7. Others

7. BY APPLICATION

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  7.1.2. Market Attractiveness Index, By Application
7.2. Dietary Supplements*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Functional Foods and Beverages
7.4. Personal Care and Beauty Products
7.5. Pet Nutrition and Supplements
7.6. Pharmaceuticals
7.7. Others

8. BY HEALTH BENEFIT

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  8.1.2. Market Attractiveness Index, By Health Benefit
8.2. Stress Reduction*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Mood Elevation
8.4. Anxiety Relief
8.5. Sleep Support
8.6. Cognitive Balance and Focus
8.7. Hormonal Mood Regulation
8.8. Others

9. BY SOURCE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  9.1.2. Market Attractiveness Index, By Source
9.2. Plant-Based*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Animal-Based
9.4. Synthetic or Bioidentical
9.5. Fermented or Biotechnological

10. BY DISTRIBUTION CHANNEL

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. B2B Ingredient Suppliers*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. B2C
  10.3.1. Online Retail
  10.3.2. Specialty Stores
  10.3.3. Pharmacies

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.8.1. US
    11.2.8.2. Canada
    11.2.8.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.8.1. Germany
    11.3.8.2. UK
    11.3.8.3. France
    11.3.8.4. Russia
    11.3.8.5. Spain
    11.3.8.6. Italy
    11.3.8.7. Norway
    11.3.8.8. Netherlands
    11.3.8.9. Sweden
    11.3.8.10. Denmark
    11.3.8.11. Belgium
    11.3.8.12. Switzerland
    11.3.8.13. Austria
    11.3.8.14. Poland
    11.3.8.15. Finland
    11.3.8.16. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.8.1. Brazil
    11.4.8.2. Argentina
    11.4.8.3. Rest of South America
11.5. Asia-Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.8.1. China
    11.5.8.2. India
    11.5.8.3. Japan
    11.5.8.4. Australia
    11.5.8.5. South Korea
    11.5.8.6. New Zealand
    11.5.8.7. Indonesia
    11.5.8.8. Malaysia
    11.5.8.9. Philippines
    11.5.8.10. Singapore
    11.5.8.11. Thailand
    11.5.8.12. Vietnam
    11.5.8.13. Rest of Asia-Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefit
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.6.8.1. UAE
    11.6.8.2. Saudi Arabia
    11.6.8.3. South Africa
    11.6.8.4. Israel
    11.6.8.5. Egypt
    11.6.8.6. Turkey
    11.6.8.7. Qatar
    11.6.8.8. Kuwait
    11.6.8.9. Oman
    11.6.8.10. Bahrain
    11.6.8.11. Rest of Middle East and Africa

12. COMPETITIVE LANDSCAPE

12.1. Competitive Scenario
12.2. Market Share Analysis – Global
12.3. Market Share Analysis – North America
12.4. Market Share Analysis - Europe
12.5. Market Share Analysis – Asia-Pacific
12.6. Mergers and Acquisitions Analysis
12.7. Partner Identification Analysis
12.8. Investment & Funding Landscape
12.9. Strategic Alliances & Innovation Pipeline

13. COMPANY PROFILES

13.1. DSM-Firmenich*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Revenue Analysis
  13.1.4. Pricing Analysis
  13.1.5. SWOT Analysis
  13.1.6. Recent Developments
    13.1.6.1. Major Deals
    13.1.6.2. M&A
    13.1.6.3. Collaboration
    13.1.6.4. Acquisition
    13.1.6.5. Joint Ventures
    13.1.6.6. Innovations
  13.1.7. Recent News
    13.1.7.1. Events
    13.1.7.2. Conferences
    13.1.7.3. Symposiums
    13.1.7.4. Webinars
13.2. BASF SE
13.3. Archer Daniels Midland Company (ADM)
13.4. Cargill, Incorporated
13.5. Kerry Group plc
13.6. Ingredion Incorporated
13.7. Tate & Lyle PLC
13.8. International Flavors & Fragrances, Inc. (IFF)
13.9. Ajinomoto Co., Inc.
13.10. Lonza Group AG (LIST NOT EXHAUSTIVE )

14. APPENDIX

14.1. About Us and Services
14.2. Contact Us